|Author(s)/Faculty: Uma Mahadevan, MD |
|Release Date: 11/24/2014||Expiration Date: 11/23/2018|
|Credit Type: CME||Number of Credits: 0.5|
|Content Type: Article||Provider: |
|Dr. Mahadeven discusses when to use therapeutic drug monitoring in the patient with inflammatory bowel disease and determining whether to increase the dose of the biologic or change the agent based on therapeutic drug monitoring.